VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,253,390 | -55.7% | 83,738 | -50.4% | 0.12% | -56.4% |
| Q2 2023 | $5,082,026 | -6.6% | 168,782 | +0.4% | 0.27% | -19.4% |
| Q1 2023 | $5,438,261 | +171.4% | 168,107 | +140.4% | 0.33% | +172.7% |
| Q4 2022 | $2,003,764 | +21.0% | 69,915 | +1.8% | 0.12% | +6.1% |
| Q3 2022 | $1,656,000 | -31.3% | 68,665 | -19.8% | 0.11% | -4.2% |
| Q2 2022 | $2,412,000 | -19.7% | 85,664 | +9.3% | 0.12% | -7.8% |
| Q1 2022 | $3,004,000 | +46.9% | 78,341 | +22.7% | 0.13% | +65.4% |
| Q4 2021 | $2,045,000 | +10.9% | 63,850 | +1.6% | 0.08% | +9.9% |
| Q3 2021 | $1,844,000 | -43.4% | 62,872 | -33.6% | 0.07% | -44.1% |
| Q2 2021 | $3,257,000 | -0.4% | 94,626 | -0.6% | 0.13% | +39.6% |
| Q1 2021 | $3,271,000 | +12.2% | 95,200 | +1.4% | 0.09% | -22.2% |
| Q4 2020 | $2,915,000 | -4.1% | 93,860 | +18.6% | 0.12% | -25.9% |
| Q3 2020 | $3,041,000 | +23.1% | 79,168 | +12.8% | 0.16% | +15.3% |
| Q2 2020 | $2,470,000 | +82.6% | 70,202 | +26.4% | 0.14% | +50.5% |
| Q1 2020 | $1,353,000 | -12.5% | 55,522 | +3.7% | 0.09% | +11.0% |
| Q4 2019 | $1,546,000 | +3.2% | 53,554 | -1.9% | 0.08% | -7.9% |
| Q3 2019 | $1,498,000 | +31.6% | 54,589 | +22.6% | 0.09% | +25.4% |
| Q2 2019 | $1,138,000 | -30.4% | 44,534 | -38.9% | 0.07% | -34.3% |
| Q1 2019 | $1,634,000 | +36.3% | 72,894 | +25.2% | 0.11% | +21.3% |
| Q4 2018 | $1,199,000 | +88.8% | 58,238 | +69.8% | 0.09% | +111.9% |
| Q3 2018 | $635,000 | +20.3% | 34,308 | +44.8% | 0.04% | +2.4% |
| Q2 2018 | $528,000 | -23.5% | 23,693 | -24.5% | 0.04% | -31.7% |
| Q1 2018 | $690,000 | -19.8% | 31,402 | -15.2% | 0.06% | -22.1% |
| Q4 2017 | $860,000 | +31.1% | 37,023 | +29.6% | 0.08% | +18.5% |
| Q3 2017 | $656,000 | -0.6% | 28,573 | -4.5% | 0.06% | -4.4% |
| Q2 2017 | $660,000 | -7.8% | 29,910 | -4.8% | 0.07% | -8.1% |
| Q1 2017 | $716,000 | +10.7% | 31,406 | +1.4% | 0.07% | -12.9% |
| Q4 2016 | $647,000 | +20.9% | 30,965 | +52.8% | 0.08% | +18.1% |
| Q3 2016 | $535,000 | -3.1% | 20,266 | +6.7% | 0.07% | -10.0% |
| Q2 2016 | $552,000 | – | 19,002 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |